Peptide Discovery
Delivering Peptide Discovery Solutions
Learn More
What We Do
Orbit Discovery provides peptide discovery services for therapeutic applications, including radionuclide targeting, nucleic acid targeting, targeted protein degradation, soluble protein targeting and GPCR agonism and antagonism.

We combine our bead-based display system and microfluidics to perform high-throughput screening across very large chemical spaces, including both linear and macrocyclic peptide development.

Our services are customizable for both affinity screening (targeting binders) and direct functional screening (especially for agonism and antagonism) using proprietary reporter cell lines.

Our mission is to help partners identify peptide therapeutic hits through advanced high-throughput affinity and functional screening techniques.

The Orbit Display Bead:
Peptide and Encoding DNA: Linked

Applications
Our Platform
Learn More

Latest Updates

Orbit Discovery to Attend Bio-Europe 2025 in Vienna
October 13, 2025

Orbit Discovery is heading to Vienna for BioEurope 2025!

Orbit Discovery to Attend the 2025 European Association of Nuclear Medicine (EANM) Annual Congress
September 29, 2025

Orbit Discovery will be attending EANM 2025 in Barcelona from Oct 4th -8th 2025.

Orbit Discovery to Sponsor the 2025 Boulder Peptide Symposium
September 1, 2025

Orbit Discovery are proud to sponsor the 2025 Boulder Peptide Foundation Symposium in beautiful Colorado 🌄

Work With Us
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs
Contact Us